GENERAL DESCRIPTION:
A product specifically designed to treat
agerelated eye disorders such as
cataracts, Conjunctisan A contains natural lysates,
which purport to improve eye conditions by stimulating the natural healing and repair processes.
Regular, longer use of conjunctisan A may improve eyesight
in cataract suffers, as well as myopia.
ROLE FOR ANTI-AGING:
Conjunctisan A’s anti-aging potential benefits
include treatment and prevention of cataracts, improvement of eye irritation due to
environmental factors, and general improvement of aging eye
deterioration due to macular degeneration, opacity of the
lens, retina changes and degenerative eye complaints.
One study found that Conjunctisan A improved the vision of 65% of cataract sufferers. Conjunctisan A is considered to be a homeopathic
medicine. When used continuously for 4 to 6 weeks some users
may benefit from improved vision; after that period, it is
important to continue a maintenance program in order for the condition not to regress.
SIDE EFFECTS/CONTRAINDICATIONS:
No known side effects or contraindications
have been reported by the manufacturer.
PHARMACOLOGY:
This product contains a plethora of bovine
origin macromolecular organ factors from corresponding eye sections. Each liquid capsule contains; 0.2ng bulb.oc. fet., 0.05ng lenx, 0.lng
fet. Vessels, 0.l5ng placenta fet., 0.05pg retina, 0.05pg
optic nerve, 0.lpg choriod, 0.lpg hyaloivd body, 0.05pg
cerebral cortx, 0.05pg diencephalon as well as the
pharmaceutical substances 0.074ug deslanoside C, 5ug
aesulin and 5ug sodium dodecyl sulfate, 4% glycerol and 0.5ml saline (0.7%).
Distribution:
Germany distributes Conjunctisan A in 0.5 ml liquid
droppers.
